Skip to main content
Livermore
Livermore
ZHEN

Ascendis Pharma A/S

ASND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001612042

In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Ascendis Pharma A/S changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of ASND: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders2812303+24
Shares63.8M1.31K64.7M+879.8K (+1.4%)
Value$12.7B$259.8K$13.8B+$1.09B (+8.6%)

2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (62)

Institutions that held Ascendis Pharma A/S at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to ASND in Q4 2025
InstitutionSharesValue% of portfolio
Nomura Asset Management International Inc.496,837$105.9M0.16%
Susquehanna International Group, LLP470,951$100.4M0.14%
IMC-Chicago, LLC113,682$24.2M0.43%
Cormorant Asset Management, LP100,000$21.3M1.21%
Defilade Capital Management, L.P.85,694$18.3M2.48%
Beck Bode, LLC81,087$17.3M2.88%
Chevy Chase Trust Holdings, Inc.56,695$12.1M0.03%
Eversept Partners, LP48,241$10.3M0.58%
Brevan Howard Capital Management LP48,260$10.2M0.19%
Affinity Asset Advisors, LLC30,000$6.40M0.46%
Balyasny Asset Management LLC24,079$5.13M0.01%
Jane Street Group, LLC21,225$4.53M0.01%
Capital Fund Management S.A.16,371$3.49M0.03%
Zweig-DiMenna Associates LLC15,500$3.31M0.23%
Rhenman & Partners Asset Management AB15,000$3.20M0.30%
Lighthouse Investment Partners, LLC12,719$2.71M0.09%
Headlands Technologies LLC11,564$2.47M0.21%
Sphera Funds Management Ltd.11,000$2.35M0.49%
Fideuram - Intesa Sanpaolo Private Banking S.P.A.10,866$2.32M0.08%
First National Bank of Omaha9,943$2.08M0.06%
Verition Fund Management LLC7,420$1.58M0.01%
Morse Asset Management, Inc6,489$1.38M0.28%
Shay Capital LLC6,000$1.28M0.21%
Vestmark Advisory Solutions, Inc.5,806$1.24M0.02%
Seven Fleet Capital Management LP5,670$1.21M0.82%
Progeny 3, Inc.5,230$1.12M0.06%
Ishara Investments LP5,000$1.07M1.24%
XTX Topco Ltd4,459$950.8K0.02%
AlphaCentric Advisors LLC3,238$690.5K0.69%
MidWestOne Financial Group, Inc.3,067$654.0K0.07%
Arrowpoint Investment Partners (Singapore) Pte. Ltd.2,997$639.1K0.09%
Csenge Advisory Group2,946$628.2K0.03%
PSP Research LLC2,579$549.9K0.48%
Severin Investments, LLC2,246$479.0K0.42%
Skopos Labs, Inc.2,217$467.8K0.02%
Scientech Research LLC2,017$430.1K0.27%
Havemeyer Place LP1,352$288.3K0.06%
Aigen Investment Management, LP1,184$252.5K0.06%
Commonwealth Equity Services, LLC1,167$248.8K0.00%
HRT Financial LP1,122$239.0K0.00%
Graham Capital Management, L.P.1,071$228.4K0.01%
Biondo Investment Advisors, LLC1,000$213.2K0.03%
SummitTX Capital, L.P.970$206.8K0.01%
Beverly Hills Private Wealth, LLC958$204.3K0.03%
State of Wyoming820$174.9K0.02%
Walleye Capital LLC628$133.9K0.00%
Greenline Wealth Management LLC504$107.5K0.11%
Penserra Capital Management LLC279$59.0K0.00%
Caitong International Asset Management Co., Ltd195$41.6K0.01%
GWM Advisors LLC90$19.2K0.00%
Elequin Capital LP51$10.9K0.00%
Commonwealth Retirement Investments LLC50$10.7K0.00%
UBS Asset Management Americas Inc25$5.33K0.00%
Bessemer Group Inc18$4.00K0.00%
Ancora Advisors, LLC12$2.56K0.00%
SageView Advisory Group, LLC6$1.28K0.00%
Cape Investment Advisory, Inc.5$1.07K0.00%
Legacy Wealth Managment, LLC3$6400.00%
PEAK6 LLC2$5000.00%
Central Trust Co2$4270.00%
Huntington National Bank1$2130.00%
DV Trading LLC1$2130.00%

Sold out (38)

Institutions that held Ascendis Pharma A/S at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of ASND in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Macquarie Group Ltd309,539$61.5M
Summit Partners Public Asset Management, LLC100,000$19.9M
Hudson Bay Capital Management LP78,934$15.7M
Great Point Partners LLC75,000$14.9M
Arrowstreet Capital, Limited Partnership60,658$12.1M
Ally Bridge Group (NY) LLC51,080$10.2M
Parkman Healthcare Partners LLC40,343$8.02M
Troluce Capital Advisors LLC30,000$5.96M
Lombard Odier Asset Management (Europe) Ltd–$5.83M
Neuberger Berman Group LLC21,049$4.18M
Readystate Asset Management LP15,570$3.10M
Zimmer Partners, LP15,500$3.08M
Avidity Partners Management LP14,500$2.88M
Natixis Advisors, L.P.11,142$2.21M
Aquatic Capital Management LLC10,854$2.16M
Acuta Capital Partners, LLC9,792$1.95M
Cinctive Capital Management LP8,376$1.67M
Quadrature Capital Ltd6,531$1.30M
Omers Administration Corp5,700$1.13M
Boothbay Fund Management, LLC5,001$994.2K
Whalen Wealth Management Inc.4,620$918.5K
Tema ETFs LLC3,682$732.0K
TD Waterhouse Canada Inc.2,790$569.5K
Groupama Asset Managment–$534.7K
National Wealth Management Group, LLC2,067$410.9K
Toronto Dominion Bank1,646$327.2K
Integrated Wealth Concepts LLC1,562$310.5K
Two Sigma Securities, LLC1,162$231.0K
Vise Technologies, Inc.1,012$201.2K
Ci Investments Inc.345$69.0K
Advisory Services Network, LLC130$25.8K
Principal Securities, Inc.87$17.3K
Truvestments Capital LLC37$7.36K
Washington Trust Advisors, Inc.30$5.96K
Private Trust Co NA11$2.19K
Transamerica Financial Advisors, Inc.1$199
Rakuten Securities, Inc.1$199
Kilter Group LLC1$199

Not filed for Q4 2025 yet (2)

Institutions that held Ascendis Pharma A/S at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ASND in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Shilanski & Associates, Inc.1,304$259.2K
Binnacle Investments Inc3$596